Developer docs
API playgroundTry for free, no card

Search company profiles

Solgent

Full company profile

uuid000dcpr

Namestring
Solgent
Websiteurl
solgent.com
Company typeenum
Private
Founded yearint
2000
Short descriptiontext

Solgent is a Daejeon, South Korea-based company founded in 2000 that manufactures molecular diagnostic kits to assess infection risk via genetic information. It is a privately held, for-profit firm with 1-10 employees and no disclosed customers, pricing, or product lineup.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersDaejeon, South Korea
HQ citystring
Daejeon
HQ countrystring
South Korea
HQ regionstring
Asia
Markets served

Serves global market

Keyword5 values
molecular diagnostics, diagnostic test kits, infectious disease detection, genetic testing kits, PCR diagnostic kits
Industry3 codes
1Molecular Diagnostics (PCR/NAAT/NGS-based IVD)
CodeHLAHAAADPrimaryYes
2Microbiology & Infectious Disease Diagnostics (Culture/ID/AST)
CodeHLAHAAACPrimaryNo
3Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels)
CodeHLAAALACPrimaryNo
NAICS code1 code
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Molecular Diagnostics
Social media profiles1 record
Cost components4 values
Supply Chain, Technology or R&D, Personnel, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Solgent manufactures molecular diagnostic kits designed to diagnose the risk of infection through genetic information analysis. The company produces physical diagnostic test kits that enable laboratories and clinical settings to detect infectious agents via molecular methods.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Molecular Diagnostic Kits
CategoryMolecular Diagnostics
No data
Peers10 records
TypeBroad incumbent
Description

Global leader in molecular diagnostics and sample technologies, including PCR-based infectious disease testing kits. Comparable as a broad incumbent offering overlapping IVD/molecular diagnostic products.

TypeEmerging player
Description

Korean molecular diagnostics company with kits for infectious disease and companion diagnostics. Comparable as a Korean molecular IVD peer with similar assay-based offerings.

TypeDirect peer
Description

Korean molecular diagnostics company developing PCR-based multiplex assays for infectious diseases. Directly comparable as a Korean-headquartered IVD manufacturer with genetic/PCR-based infectious disease kits.

TypeBroad incumbent
Description

Major IVD provider with a broad molecular diagnostics portfolio including infectious disease real-time PCR assays. Comparable as a broad incumbent serving clinical labs globally.

TypeDirect peer
Description

Korean developer of molecular diagnostic kits including infectious disease PCR assays. Direct peer in the molecular IVD space serving similar clinical and research customers.

TypeDirect peer
Description

Korean IVD manufacturer with a strong portfolio of molecular and rapid diagnostic kits for infectious disease. Closely comparable in target customers and product category.

TypeEmerging player
Description

Korean molecular diagnostics firm offering PCR-based kits for infectious disease and oncology. Comparable as an emerging Korean player focused on molecular assay development.

TypeBroad incumbent
Description

Global in vitro diagnostics company with significant microbiology and molecular diagnostics offerings. Overlaps with Solgent's infectious disease diagnostic focus.

TypeDirect peer
Description

Korean molecular diagnostics and life sciences company offering PCR-based infectious disease kits and instruments. Comparable as a Daejeon-area Korean molecular IVD peer.

TypeBroad incumbent
Description

Diversified diagnostics and medical technology company with a molecular diagnostics business targeting infectious disease. Comparable as a broad incumbent offering competing molecular infectious disease assays.

Market position
Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Solgent

Molecular Diagnosticssolgent.com

Solgent is a Daejeon, South Korea-based company founded in 2000 that manufactures molecular diagnostic kits to assess infection risk via genetic information. It is a privately held, for-profit firm with 1-10 employees and no disclosed customers, pricing, or product lineup.

Solgent firmographics

Firmographics
Name
Solgent
Website
https://solgent.com
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
1–10 employees
Short description
Solgent is a Daejeon, South Korea-based company founded in 2000 that manufactures molecular diagnostic kits to assess infection risk via genetic information. It is a privately held, for-profit firm with 1-10 employees and no disclosed customers, pricing, or product lineup.
Ownership category
akta.pro rank

Solgent industry classification

Industry
Product category
Molecular Diagnostics
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro primary industry
Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD)
akta.pro secondary industries
Microbiology & Infectious Disease Diagnostics (Culture/ID/AST) (HLAHAAAC), Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels) (HLAAALAC)

Keywords

  • Molecular diagnostics
  • Diagnostic test kits
  • Infectious disease detection
  • Genetic testing kits
  • PCR diagnostic kits

Where Solgent is headquartered

Location

Headquarters

HQ city
Daejeon
HQ country
South Korea
HQ region
Asia

Markets served

Solgent business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Personnel, Operations

Solgent product offering

Product offering

Core offering

Solgent manufactures molecular diagnostic kits designed to diagnose the risk of infection through genetic information analysis. The company produces physical diagnostic test kits that enable laboratories and clinical settings to detect infectious agents via molecular methods.

Differentiator

Problem solved

Functional benefit

Products and services

  • Molecular Diagnostic Kits

Companies that use Solgent

Customer profile

Ideal customer profiles1 record

Solgent technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Solgent competitors and assessment

Company assessment

Broad incumbents

  • Qiagen: Global leader in molecular diagnostics and sample technologies, including PCR-based infectious disease testing kits. Comparable as a broad incumbent offering overlapping IVD/molecular diagnostic products.
  • Abbott Molecular: Major IVD provider with a broad molecular diagnostics portfolio including infectious disease real-time PCR assays. Comparable as a broad incumbent serving clinical labs globally.
  • bioMérieux: Global in vitro diagnostics company with significant microbiology and molecular diagnostics offerings. Overlaps with Solgent's infectious disease diagnostic focus.
  • Hologic (Panther Fusion): Diversified diagnostics and medical technology company with a molecular diagnostics business targeting infectious disease. Comparable as a broad incumbent offering competing molecular infectious disease assays.

Emerging players

  • Gencurix: Korean molecular diagnostics company with kits for infectious disease and companion diagnostics. Comparable as a Korean molecular IVD peer with similar assay-based offerings.
  • GeneMatrix: Korean molecular diagnostics firm offering PCR-based kits for infectious disease and oncology. Comparable as an emerging Korean player focused on molecular assay development.

Direct peers

  • Seegene: Korean molecular diagnostics company developing PCR-based multiplex assays for infectious diseases. Directly comparable as a Korean-headquartered IVD manufacturer with genetic/PCR-based infectious disease kits.
  • Kogene Biotech: Korean developer of molecular diagnostic kits including infectious disease PCR assays. Direct peer in the molecular IVD space serving similar clinical and research customers.
  • SD Biosensor: Korean IVD manufacturer with a strong portfolio of molecular and rapid diagnostic kits for infectious disease. Closely comparable in target customers and product category.
  • Bioneer: Korean molecular diagnostics and life sciences company offering PCR-based infectious disease kits and instruments. Comparable as a Daejeon-area Korean molecular IVD peer.

Market position

Customer concentration

Solgent social profiles

Digital presence

Solgent financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Solgent leadership team

Management profile

Number of profiles

Solgent funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Solgent M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Solgent

What does Solgent do?

Solgent manufactures molecular diagnostic kits designed to diagnose the risk of infection through genetic information analysis. The company produces physical diagnostic test kits that enable laboratories and clinical settings to detect infectious agents via molecular methods.

When was Solgent founded?

Solgent was founded in 2000. It employs 1 to 10 people.

Where is Solgent based?

Solgent is headquartered in Daejeon, South Korea, in the Asia region.

Who are Solgent's main competitors?

Broad incumbents on record are Qiagen, Abbott Molecular, bioMérieux and Hologic (Panther Fusion). Emerging players are Gencurix and GeneMatrix. Direct peers are Seegene, Kogene Biotech, SD Biosensor and Bioneer.

Does Solgent have an API?

No public API is recorded for Solgent.

What industry is Solgent in?

Solgent's product category is Molecular Diagnostics. Its primary akta.pro industry code is HLAHAAAD, Molecular Diagnostics (PCR/NAAT/NGS-based IVD), with a secondary code of HLAHAAAC, Microbiology & Infectious Disease Diagnostics (Culture/ID/AST). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales